Literature DB >> 22477015

A Trp33Arg mutation at exon 1 of the MYH9 gene in a Korean patient with May-Hegglin anomaly.

Moon Ju Jang1, Hyun-Jeong Park, So Young Chong, Ji Young Huh, In-Ho Kim, Ja-Hyun Jang, Hee-Jin Kim, Doyeun Oh.   

Abstract

In this report, we describe a Korean patient with May-Hegglin anomaly from a mutation of the MYH9 gene. The proband was a 21-year-old man with thrombocytopenia. He did not have a bleeding tendency. His neutrophil count was normal at 7490/mm³; however, the neutrophils contained abnormal basophilic inclusions in their cytoplasm. The platelet count was decreased at 15,000/mm³ with giant platelets. Coagulation test results were not remarkable. Direct sequencing of MYH9 revealed that he was heterozygous for a mutation in exon 1, which was a 97T>A substitution mutation affecting codon 33, substituting tryptophan with arginine (Trp33Arg). Family study showed that both of his parents had normal phenotype and genotypes, indicating a de novo occurrence of the mutation in the proband.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22477015      PMCID: PMC3343441          DOI: 10.3349/ymj.2012.53.3.662

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  14 in total

1.  [Not Available].

Authors:  R HEGGLIN
Journal:  Helv Med Acta       Date:  1945-07

2.  [The MYH9 syndrome: report of a new case with a new mutation of the MYH9 gene].

Authors:  N Schleinitz; R Favier; K Mazodier; A Difeo; M Ebbo; V Veit; Y Berda-Haddad; E Bernit; P Heudier; G Kaplanski; L Camoin; V Bardet; J-R Harle
Journal:  Rev Med Interne       Date:  2006-08-15       Impact factor: 0.728

3.  Accumulation of MYH9 mRNA at leukocyte inclusion bodies in MYH9 disorders.

Authors:  Shinji Kunishima; Kyoko Hirano; Motohiro Hamaguchi; Hidehiko Saito
Journal:  Eur J Haematol       Date:  2008-07-09       Impact factor: 2.997

4.  First description of somatic mosaicism in MYH9 disorders.

Authors:  Shinji Kunishima; Tadashi Matsushita; Takao Yoshihara; Yoko Nakase; Kentaro Yokoi; Motohiro Hamaguchi; Hidehiko Saito
Journal:  Br J Haematol       Date:  2005-02       Impact factor: 6.998

5.  Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.

Authors:  M J Kelley; W Jawien; T L Ortel; J F Korczak
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.

Authors:  S Kunishima; T Matsushita; T Kojima; N Amemiya; Y M Choi; N Hosaka; M Inoue; Y Jung; S Mamiya; K Matsumoto; Y Miyajima; G Zhang; C Ruan; K Saito; K S Song; H J Yoon; T Kamiya; H Saito
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

7.  Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disorders.

Authors:  Shinji Kunishima; Tadashi Matsushita; Motohiro Hamaguchi; Hidehiko Saito
Journal:  Eur J Haematol       Date:  2008-02-13       Impact factor: 2.997

8.  Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders.

Authors:  Shinji Kunishima; Motohiro Hamaguchi; Hidehiko Saito
Journal:  Blood       Date:  2008-01-11       Impact factor: 22.113

9.  Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium.

Authors:  M Seri; R Cusano; S Gangarossa; G Caridi; D Bordo; C Lo Nigro; G M Ghiggeri; R Ravazzolo; M Savino; M Del Vecchio; M d'Apolito; A Iolascon; L L Zelante; A Savoia; C L Balduini; P Noris; U Magrini; S Belletti; K E Heath; M Babcock; M J Glucksman; E Aliprandis; N Bizzaro; R J Desnick; J A Martignetti
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

10.  Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutations.

Authors:  Alessandro Pecci; Ilaria Canobbio; Alessandra Balduini; Lucia Stefanini; Barbara Cisterna; Carmela Marseglia; Patrizia Noris; Anna Savoia; Carlo L Balduini; Mauro Torti
Journal:  Hum Mol Genet       Date:  2005-09-14       Impact factor: 6.150

View more
  5 in total

1.  MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.

Authors:  Alessandro Pecci; Catherine Klersy; Paolo Gresele; Kieran J D Lee; Daniela De Rocco; Valeria Bozzi; Giovanna Russo; Paula G Heller; Giuseppe Loffredo; Matthias Ballmaier; Fabrizio Fabris; Eloise Beggiato; Walter H A Kahr; Nuria Pujol-Moix; Helen Platokouki; Christel Van Geet; Patrizia Noris; Preethi Yerram; Cedric Hermans; Bernhard Gerber; Marina Economou; Marco De Groot; Barbara Zieger; Erica De Candia; Vincenzo Fraticelli; Rogier Kersseboom; Giorgina B Piccoli; Stefanie Zimmermann; Tiziana Fierro; Ana C Glembotsky; Fabrizio Vianello; Carlo Zaninetti; Elena Nicchia; Christiane Güthner; Carlo Baronci; Marco Seri; Peter J Knight; Carlo L Balduini; Anna Savoia
Journal:  Hum Mutat       Date:  2013-12-12       Impact factor: 4.878

2.  Genetic classification and confirmation of inherited platelet disorders: current status in Korea.

Authors:  Ye Jee Shim
Journal:  Clin Exp Pediatr       Date:  2020-02-06

3.  Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variants.

Authors:  Loredana Bury; Karyn Megy; Jonathan C Stephens; Luigi Grassi; Daniel Greene; Nick Gleadall; Karina Althaus; David Allsup; Tadbir K Bariana; Mariana Bonduel; Nora V Butta; Peter Collins; Nicola Curry; Sri V V Deevi; Kate Downes; Daniel Duarte; Kim Elliott; Emanuela Falcinelli; Bruce Furie; David Keeling; Michele P Lambert; Rachel Linger; Sarah Mangles; Rutendo Mapeta; Carolyn M Millar; Christopher Penkett; David J Perry; Kathleen E Stirrups; Ernest Turro; Sarah K Westbury; John Wu; Nihr BioResource; Keith Gomez; Kathleen Freson; Willem H Ouwehand; Paolo Gresele; Ilenia Simeoni
Journal:  Hum Mutat       Date:  2019-10-15       Impact factor: 4.878

4.  Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-Related Disorders.

Authors:  Béatrice Saposnik; Sylvie Binard; Odile Fenneteau; Alan Nurden; Paquita Nurden; Marie-Françoise Hurtaud-Roux; Nicole Schlegel
Journal:  Mol Genet Genomic Med       Date:  2014-02-07       Impact factor: 2.183

5.  A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature.

Authors:  Qi Ai; Linsheng Zhao; Jing Yin; Lihua Jiang; Qiuying Jin; Xiaoli Hu; Sen Chen
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.